| Product Name |
Atazanavir-d9
|
| Product Code |
DA-A324-37
|
| Chemical name |
Atazanavir-d9
|
| Synonyms |
3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl Ester-d9; (3S,8S, 9S, 12S)-2,5,6,13-Pentaazatetradecanedioic Acid; BMS-232632-d9; CGP-73547-d9;
|
| Impurity |
NA
|
| CAS Number |
1092540-51-6
|
| Alternate CAS # |
NA
|
| Molecular form |
C38H43D9N6O7
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
713.91
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
chiral standards,enzyme inhibitors,pharmaceutical standards,intermediates,fine chemicals,stable isotopes
|
| Boiling Point |
NA
|
| Applications |
Atazanavir-d9 is the deuterated analog of Atazanavir, a azapeptide HIV protease inhibitor derivative. Atazanavir have been investigated as potential treatment of human immunodeficiency virus (HIV) and for anticancer purposes.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
